Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s

LONDON: Scientists have developed a drug with potential to stop the breakdown of nerves and brain cells that may lead to Alzheimer’s, Parkinson’s and motor neuron disease.

Alzheimer’s disease is the most common type of dementia, which includes memory loss, confusion and problems with speech and understanding.

The drug is made up of “supercharged” vitamin A, which is found in vegetables like sprouts and carrots and miniature cabbages, the Daily Mail reported.

The study showed that vitamin A turns into a chemical called retinoic acid when broken down by the body, which is crucial for the development of the nervous system.

Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s
Higher levels of retinoic acid in the body could halt nerve damage and boost the number of nerve cells.

“We are moving forward with a new therapeutic which could be used to help people with Alzheimer’s disease,” Peter McCaffery, lead author and Professor from the Aberdeen University in Scotland, was quoted as saying.

“Our work is still at an early stage but we believe this is a positive development and the new drugs seem to protect nerve cells” he added.

With vitamin A making a difference, it is important to find ways of tackling neurological conditions, McCaffery said.

In addition, the drug may also benefit ALS or Lou Gehrig’s disease, which affects the muscles of the arms, legs, mouth and respiratory system.

  • Related Posts

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

    Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

    Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

    Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

    Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

    5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

    5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

    AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

    AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure